by Joel Rothman | Jan 8, 2010 | NutriSupLaw
Marketers of nutritional supplements often complain that they do not know what the FDA wants. Even after the agency sends a warning letter about misleading claims and advertising, its staff does not explain what would fall within the rules. That’s the reality;...
by Joel Rothman | Jan 3, 2010 | NutriSupLaw
2009 was an incredible year for the dietary supplement industry. While the rest of American business floundered amidst the depths of a recession, the dietary supplement business thrived. Americans concerned about maintaining their good health stocked up on...
by Joel Rothman | Nov 28, 2009 | NutriSupLaw
David Frum recently laid into the nutritional supplement industry with a guest commentary on CNN.com. The resident fellow at the American Enterprise Institute and one-time special assistant to President George W. Bush lashed out with the classic invectives against...
by Joel Rothman | Nov 22, 2009 | NutriSupLaw
The headline in the Wall Street Journal read, “New Study Gives B Vitamin a Boost” and the first sentence in the article was, “Bring out the niacin.” It turned out that a vitamin — even only a prescription formula — produced better...
by Joel Rothman | Nov 16, 2009 | NutriSupLaw
Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyper-linked line that warns consumers about the potential dangers of a drug....